Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 46 min ago
Peer-reviewedCC BY-NC-ND 4.0Systematic Reviews

Persistent Staphylococcus aureus bacteremia and 30-day mortality: a systematic review and meta-analysis

  1. 1Division of Infectious Diseases (Department of Internal Medicine), All India Institute of Medical Sciences, Jodhpur, 342005 India
  2. 2Department of Infectious Diseases, Indus International Hospital, Mohali, India

Abstract

Background: A substantial proportion of patients with Staphylococcus aureus bacteremia (SAB) continue to have persistent culture positivity. However, the magnitude and consistency of its association with mortality remain uncertain.

Methods: Data were extracted from PubMed/MEDLINE, Embase, Scopus, and the Cochrane Library from inception to January 2026. Observational studies comparing 30-day all-cause mortality between S. aureus persistent and non-persistent bacteremia were included. Persistent bacteremia was defined as continued positivity of blood cultures for S. aureus for ≥ 48 h after initiation of appropriate antimicrobial therapy. Risk of bias and quality were evaluated with the ROBINS-E tool. Pooled odds ratios (ORs) for 30-day mortality were estimated using a random-effects meta-analysis model. Heterogeneity was investigated through subgroup analyses, sensitivity analyses, and meta-regression.

Results: Nineteen studies comprising 7,993 patients with SAB met the inclusion criteria. In pooled unadjusted analysis, persistent bacteremia was associated with increased 30 day all-cause mortality (OR 1.97, 95% CI 1.62–2.40, I2 = 34%). Adjusted mortality data accounting for additional patient characteristics were available from 9 studies (5,775 patients), and revealed a similar increased mortality rate in persistent bacteremia compared to non-persistent bacteremia (OR 2.81, 95% CI 1.59–4.96, I2 = 91%). Meta-regression showed no significant influence of age, proportion of methicillin-resistant S. aureus, or hospital-acquired infection on the pooled mortality. No evidence of publication bias was detected.

Conclusions: In this meta-analysis, patients with S. aureus persistent bacteremia had a higher mortality risk than those with non-persistent bacteremia. Future research should target this high-risk phenotype to improve outcomes in SAB.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13643-026-03289-5.

Related

  1. Persistent Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Due to Pelvic Pyomyositis and Abscesses With Extension Through the Sciatic Notch: A Case Report.
    Nastaran Biriji, Dylan Mooney, Andrew Hamilton
    CureusPeer-reviewedCC BYFull textMedical imaging & radiologyInfectious diseaseEurope PMCPMC
  2. Factors associated with mortality in Staphylococcus aureus bacteremia: the role of infectious diseases consultation
    Ceyda Geyiktepe-Guclu, Serkan Surme, Kadir Gorkem Guclu +3
    BMC Infectious DiseasesPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseasePMC
  3. Cefazolin versus Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    F. Pozzebon, G. Pacheco, G. Cabral +3
    medRxivPreprintCC BY-NC-NDFull textInfectious diseasemedRxiv
  4. Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
    The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group
    New England Journal of MedicinePeer-reviewedLicence not stated24 citedInfectious diseaseOpenAlex
  5. Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence
    Michihiko Goto
    JAMA Network OpenPeer-reviewedCC BY 4.0General medicineCrossref
BibTeX
@article{meena2026persistent,
  title = {{Persistent Staphylococcus aureus bacteremia and 30-day mortality: a systematic review and meta-analysis}},
  author = {Durga Shankar Meena and Deepak Kumar and Navneet Kaur and Gopal Krishana Bohra},
  journal = {Systematic Reviews},
  year = {2026},
  month = aug,
  doi = {10.1186/s13643-026-03289-5},
  url = {https://doi.org/10.1186/s13643-026-03289-5},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Persistent Staphylococcus aureus bacteremia and 30-day mortality: a systematic review and meta-analysis
AU  - Durga Shankar Meena
AU  - Deepak Kumar
AU  - Navneet Kaur
AU  - Gopal Krishana Bohra
PY  - 2026
DA  - 2026/08/12
JO  - Systematic Reviews
DO  - 10.1186/s13643-026-03289-5
UR  - https://doi.org/10.1186/s13643-026-03289-5
AB  - Background: A substantial proportion of patients with Staphylococcus aureus bacteremia (SAB) continue to have persistent culture positivity. However, the magnitude and consistency of its association with mortality remain uncertain.  Methods: Data were extracted from PubMed/MEDLINE, Embase, Scopus, and the Cochrane Library from inception to January 2026. Observational studies comparing 30-day all-cause mortality between S. aureus persistent and non-persistent bacteremia were included. Persistent bacteremia was defined as continued positivity of blood cultures for S. aureus for ≥ 48 h after initiation of appropriate antimicrobial therapy. Risk of bias and quality were evaluated with the ROBINS-E tool. Pooled odds ratios (ORs) for 30-day mortality were estimated using a random-effects meta-analysis model. Heterogeneity was investigated through subgroup analyses, sensitivity analyses, and meta-regression.  Results: Nineteen studies comprising 7,993 patients with SAB met the inclusion criteria. In pooled unadjusted analysis, persistent bacteremia was associated with increased 30 day all-cause mortality (OR 1.97, 95% CI 1.62–2.40, I2 = 34%). Adjusted mortality data accounting for additional patient characteristics were available from 9 studies (5,775 patients), and revealed a similar increased mortality rate in persistent bacteremia compared to non-persistent bacteremia (OR 2.81, 95% CI 1.59–4.96, I2 = 91%). Meta-regression showed no significant influence of age, proportion of methicillin-resistant S. aureus, or hospital-acquired infection on the pooled mortality. No evidence of publication bias was detected.  Conclusions: In this meta-analysis, patients with S. aureus persistent bacteremia had a higher mortality risk than those with non-persistent bacteremia. Future research should target this high-risk phenotype to improve outcomes in SAB.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13643-026-03289-5.
SN  - 2046-4053
ER  -